Nitrous oxide

Description

Nitrous Oxide USP is a non-flammable gas with the chemical abstract service (CAS) number 10024-97-2. It is classified as an oxidizer with a rating of 5.1.

Uses and Indications

This drug is indicated for use in specific medical settings where the administration of Nitrous Oxide is deemed appropriate. It is essential that Nitrous Oxide be administered only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

WARNING: This product contains a chemical known to the state of California to cause birth defects or other reproductive harm.

Limitations of use regarding the administration of Nitrous Oxide should be strictly adhered to, ensuring that it is utilized in accordance with established medical guidelines and under appropriate supervision.

Dosage and Administration

Administration of Nitrous Oxide is indicated for use only by or under the supervision of a licensed practitioner experienced in its use and administration, as it may pose hazards or be contraindicated in certain situations.

The route of administration is via respiratory inhalation. The active ingredient is Nitrous Oxide, provided in a concentration of 990 mL within a 1 L container. It is essential that practitioners adhere to established protocols and guidelines when administering this agent to ensure patient safety and efficacy.

Contraindications

Administration of Nitrous Oxide is contraindicated in the following situations:

• Use is restricted to licensed practitioners experienced in its administration, due to the potential hazards associated with its use.

• Handling of Nitrous Oxide should not occur until all safety precautions have been thoroughly read and understood.

• Direct contact with eyes, skin, or clothing is prohibited to prevent adverse reactions.

• Inhalation of the gas should be avoided to mitigate respiratory risks.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazards and Risks Nitrous Oxide is classified as a DANGER due to its potential to cause or intensify fire; it is an oxidizer that contains gas under pressure and may explode if subjected to heat. Additionally, exposure to Nitrous Oxide may result in drowsiness or dizziness, and it has the potential to displace oxygen, leading to rapid suffocation. Frostbite is another risk associated with this substance. Furthermore, it is important to note that this product contains a chemical recognized by the state of California as a potential cause of birth defects or other reproductive harm.

General Precautions Prior to handling Nitrous Oxide, all safety precautions must be thoroughly read and understood. It is essential to store and keep the gas away from clothing and other combustible materials. Valves and fittings should be maintained free from grease and oil, and inhalation of the gas should be avoided. Direct contact with eyes, skin, or clothing must be prevented. Nitrous Oxide should only be used and stored outdoors or in well-ventilated areas. In the event of a fire, efforts should be made to stop the leak if it is safe to do so. A backflow preventive device should be utilized in the piping, and only equipment that is compatible with the materials of construction and rated for cylinder pressure should be employed. Equipment must also be cleaned for oxygen service. Valves should be opened slowly and closed after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52 degrees C (125 degrees F). It is crucial to read and follow the Safety Data Sheet (SDS) prior to use.

Emergency and Medical Attention In the event of feeling unwell, it is advised to contact a poison center or a physician immediately. If Nitrous Oxide comes into contact with the skin, immediate medical advice should be sought. Thaw any frostbitten areas with lukewarm water, ensuring not to rub the affected area.

Side Effects

Patients receiving nitrous oxide may experience a range of adverse reactions, which can be categorized by seriousness and frequency.

Serious adverse reactions include the potential for drowsiness or dizziness, which may impair the ability to perform tasks requiring mental alertness. Additionally, nitrous oxide may displace oxygen, leading to rapid suffocation, and it is important to note that the gas is an oxidizer that can cause or intensify fire; it is stored under pressure and may explode if heated. Frostbite is another serious risk associated with exposure to nitrous oxide, particularly if the gas is released inappropriately.

Furthermore, it is critical to inform patients that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm.

Healthcare providers should monitor patients for these adverse reactions and ensure that appropriate safety measures are in place to mitigate risks associated with the use of nitrous oxide.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide in pediatric patients may pose hazards or be contraindicated. It is essential that it be used only by or under the supervision of a licensed practitioner who has experience in the use and administration of Nitrous Oxide. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Monitoring for efficacy and adverse effects is recommended in this population, given the lack of targeted data.

Pregnancy

This product contains a chemical known to the state of California to cause birth defects or other reproductive harm. Pregnant patients should be advised of the potential risks associated with exposure to this product. Healthcare professionals are encouraged to weigh the benefits against the risks when considering the use of this product in women of childbearing potential. It is recommended that alternative therapies be considered for pregnant patients or those planning to become pregnant. Close monitoring and counseling regarding the potential fetal impacts should be provided to ensure informed decision-making.

Lactation

Lactating mothers should be aware that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm. Due to the potential risks associated with this chemical, caution is advised when considering the use of this product during breastfeeding.

Healthcare professionals should evaluate the benefits and risks of administering this product to lactating mothers, taking into account the potential effects on breastfed infants. Further studies may be necessary to fully understand the implications of this product's use in nursing populations.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If the specific agent involved in the overdose is known, appropriate antidotes or treatments should be administered as per established guidelines. Continuous monitoring of the patient’s condition is crucial, and further interventions may be required based on the evolving clinical picture.

It is advisable for healthcare professionals to consult local poison control centers or toxicology experts for guidance on managing specific overdose cases. Documentation of the incident and any interventions performed is also critical for ongoing patient care and legal considerations.

Nonclinical Toxicology

This product contains a chemical known to the state of California to cause birth defects or other reproductive harm. The implications of this finding underscore the importance of careful consideration regarding the use of this product in populations that may be at risk, particularly during pregnancy.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: drowsiness, dizziness, and frostbite. Additionally, it is noted that this product contains a chemical recognized by the state of California as a substance that may cause birth defects or other reproductive harm.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may be hazardous or contraindicated and is intended for use only by or under the supervision of a licensed practitioner experienced in its use. It is essential that the practitioner is familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is an oxidizer that contains gas under pressure and may explode if heated. They should be informed that the gas may cause drowsiness or dizziness and has the potential to displace oxygen, leading to rapid suffocation. Additionally, patients should be cautioned about the risk of frostbite.

It is crucial for patients to understand the importance of reading and comprehending all safety precautions before handling Nitrous Oxide. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing the gas and should not allow it to come into contact with their eyes, skin, or clothing. Furthermore, Nitrous Oxide should only be used and stored outdoors or in a well-ventilated area.

In the event of a fire, patients should be advised to stop the leak if it is safe to do so. They should be informed about the necessity of using a backflow preventive device in the piping and that only equipment made of compatible materials and rated for cylinder pressure should be utilized. It is also important to use equipment that has been cleaned for oxygen service, to open the valve slowly, and to close the valve after each use and when the cylinder is empty. Patients should protect the gas from sunlight when the ambient temperature exceeds 52 degrees C (125 degrees F) and are encouraged to read and follow the Safety Data Sheet (SDS) prior to use.

In case of an emergency, patients should be instructed on first aid measures: if inhaled, they should be removed to fresh air and kept comfortable for breathing, and a poison center or physician should be contacted if they feel unwell. If Nitrous Oxide comes into contact with the skin, patients should thaw the affected area with lukewarm water without rubbing it and seek immediate medical advice or attention.

Lastly, healthcare providers should inform patients that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm.

Storage and Handling

The product is supplied in configurations that ensure safe handling and storage. It is essential to keep the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be maintained free from grease and oil to ensure proper functioning and safety.

Users are advised to avoid breathing the gas and to refrain from contact with eyes, skin, or clothing. The product should only be used and stored outdoors or in a well-ventilated area to minimize inhalation risks.

When ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit), it is crucial to protect the product from direct sunlight to maintain its integrity. Users should open the valve slowly and ensure it is closed after each use and when the product is empty to prevent leaks and ensure safety.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Metro Welding Supply Corporation. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)